Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Common Equity (2016 - 2026)

Pediatrix Medical (MD) has disclosed Common Equity for 17 consecutive years, with $865.9 million as the latest value for Q4 2025.

  • Quarterly Common Equity rose 13.19% to $865.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $865.9 million through Dec 2025, up 13.19% year-over-year, with the annual reading at $865.9 million for FY2025, 13.19% up from the prior year.
  • Common Equity for Q4 2025 was $865.9 million at Pediatrix Medical, down from $890.7 million in the prior quarter.
  • The five-year high for Common Equity was $968.0 million in Q3 2023, with the low at $706.5 million in Q2 2024.
  • Average Common Equity over 5 years is $845.0 million, with a median of $852.6 million recorded in 2023.
  • The sharpest move saw Common Equity crashed 48.43% in 2021, then grew 21.59% in 2025.
  • Over 5 years, Common Equity stood at $896.7 million in 2021, then decreased by 0.56% to $891.6 million in 2022, then decreased by 4.77% to $849.1 million in 2023, then decreased by 9.91% to $764.9 million in 2024, then increased by 13.19% to $865.9 million in 2025.
  • According to Business Quant data, Common Equity over the past three periods came in at $865.9 million, $890.7 million, and $833.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.